Perioperative antiplatelet therapy - Zurich Open Repository and Archive
... Perioperative antiplatelet therapy Copy Abstract Aspirin is recommended as a lifelong therapy that ... induced by surgery, early withdrawal of antiplatelet therapy for secondary prevention of cardiovascular ... Perioperative antiplatelet therapy - Zurich Open Repository and Archive ... Perioperative antiplatelet therapy - Zurich Open Repository and Archive Header Quicknavigation Home ... Perioperative antiplatelet therapy - Zurich Open Repository and Archive ...
Management of aneurysmal subarachnoid hemorrhage patients with anti...
... Management of aneurysmal subarachnoid hemorrhage patients with antiplatelet use before the initial ... complications is the use of antiplatelet medication before the initial hemorrhage. The goal of this survey was ... Management of aneurysmal subarachnoid hemorrhage patients with antiplatelet use before the initial ... Management of aneurysmal subarachnoid hemorrhage patients with antiplatelet use before the initial ... Management of aneurysmal subarachnoid hemorrhage patients with antiplatelet use before the initial ...
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelo...
... extended duration of antiplatelet therapy, and a novel aspirin-free antiplatelet regimen after SPCI should ... which is a randomized, open-label trial, comparing an experimental regimen of 1-month dual antiplatelet ... Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23 ... Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23 ... Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23 ...
Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebro...
... Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents Copy Abstract ... PURPOSE: The perioperative treatment of patients on dual antiplatelet therapy after myocardial infarction ... Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents - Zurich Open ... Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents - Zurich Open ... Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents - Zurich Open ...
Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs -...
... in emergency room patients who are currently being treated with anticoagulant or antiplatelet ... to safely adjust anticoagulant and antiplatelet therapy when GI bleeding occurs.The investigators ... Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs - Zurich Open Repository and ... Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs - Zurich Open Repository and ... Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs - Zurich Open Repository and ...
Novel anticoagulants in the therapy of peripheral arterial and coro...
... . Copy Abstract Anticoagulant and antiplatelet drugs are used and studied in numerous trials for primary ... combination of aspirin and warfarin to improve prevention of atherothrombosis compared to antiplatelet therapy ... Abstract Anticoagulant and antiplatelet drugs are used and studied in numerous trials for primary and ... aspirin and warfarin to improve prevention of atherothrombosis compared to antiplatelet therapy alone was ...
Efficacy and safety of one-month DAPT followed by 23-month ticagrel...
... Data on optimal antiplatelet therapy in patients undergoing stenting of the proximal left anterior ... difference in the risk of the primary endpoint between the two antiplatelet strategies (3.38% vs. 3.93 ... Abstract BACKGROUNDS Data on optimal antiplatelet therapy in patients undergoing stenting of the proximal ... , there was no significant difference in the risk of the primary endpoint between the two antiplatelet ...
Haemostaseological complication management in caval and iliac venou...
... Copy Abstract Antiplatelet and anticoagulation therapy after venous stenting is still not ... caval vein occlusion in a patient with severe postthrombotic syndrome. Abstract Antiplatelet and ... Antiplatelet and anticoagulation therapy after venous stenting is still not standardized, data from randomized ... severe postthrombotic syndrome. Abstract Antiplatelet and anticoagulation therapy after venous stenting ...
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ...
... ) ( antiplatelet group). The primary efficacy outcome was the composite of death or thromboembolic events. The ... in the rivaroxaban group and in 78 patients in the antiplatelet group (incidence rates, 9.8 and 7.2 ... ) ( antiplatelet group). The primary efficacy outcome was the composite of death or thromboembolic events. The ... in the rivaroxaban group and in 78 patients in the antiplatelet group (incidence rates, 9.8 and 7.2 ...
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessa...
... Abstract BACKGROUND Early withdrawal of recommended antiplatelet treatment with clopidogrel ... adversely affects prognosis following percutaneous coronary interventions. Optimal antiplatelet treatment is ... withdrawal of recommended antiplatelet treatment with clopidogrel adversely affects prognosis following ... percutaneous coronary interventions. Optimal antiplatelet treatment is essential following ST-segment elevation ...
